Artrya (ASX:AYA) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


ASX:AYA Artrya Ltd ASX:AYA
30 GF Score
Price A$5.21
! 1 Warning Sign
View Full Analysis

What is Artrya Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Artrya's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.


ASX:AYA vs VEEV, BTSG, TEM: Margin of Safety % (DCF FCF Based) Comparison

For the Health Information Services subindustry, Artrya's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Artrya Margin of Safety % (DCF FCF Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Artrya's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Artrya's Margin of Safety % (DCF FCF Based) falls into.


ASX:AYA
30GF Score
Artrya Ltd ASX:AYA
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artrya Business Description

Address 1257 Hay Street, West Perth, Perth, WA, AUS, 6005
Artrya Ltd is a medical technology company. The company is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. It is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.
30GF Score

Get the complete analysis for ASX:AYA

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$5.21
Price